title: Imaging features following transarterial chemoembolization and radiofrequency ablation of hepatocellular carcinoma.
abstract: Transarterial chemoembolization and radiofrequency ablation are currently the most widely used modalities in the minimally invasive treatment of unresectable hepatocellular carcinoma. This article briefly summarizes the minimally invasive therapeutic options in the management of hepatocellular carcinoma focusing on transarterial chemoembolization and radiofrequency ablation and describes normal post-treatment imaging appearances. Imaging features of post-treatment local tumor recurrence as well as procedure-related complications following these interventions have also been described.
authors.affiliation: Section of Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA 02215, USA. ibrennan@bidmc.harvard.edu
authors.forename: Ian M
authors.initials: IM
authors.lastname: Brennan
authors.forename: Muneeb
authors.initials: M
authors.lastname: Ahmed
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000628:therapy*; D017115:Catheter Ablation / Q000009:adverse effects*; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects*; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications* / Q000175:diagnosis*; D025321:Surgery, Computer-Assisted / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents